Comments
Commented by Fabian Lorenz on March 14th, 2024 | 06:30 CET
Aixtron, Standard Lithium, Edison Lithium: Up to 200% upside potential!
The Aixtron share is working on a comeback. The last few trading days have been positive, and an analyst commentary also gives hope that the crash is over. After all, the medium-term prospects of the plant engineering company are considered promising. Lithium also appears to be recovering. The long-term prospects for the sector are promising. In the case of Standard Lithium, support at USD 1 has held, and analysts see a price potential of more than 200%. At Edison Lithium, a spin-off is creating price fantasy. Will the IPO of the cobalt business bring about a turnaround? In its core business, the Company is focusing on the raw material for the next generation of batteries.
Read
Commented by Juliane Zielonka on March 14th, 2024 | 06:15 CET
Porsche, First Hydrogen, Mercedes-Benz: Which shares offer growth potential in the transformation phase towards clean energy?
The German automotive industry is facing drastic changes, one of the biggest transformation phases in history. The "Green Deal" is forcing car manufacturers to completely overhaul their requirements and supply chains. Porsche announces the introduction of hybrid drive in its popular 911 models, and the Macan is set to be offered entirely as an electric vehicle. However, CEO Blume links the transition to an important condition. Forecasts by McKinsey show that clean hydrogen will account for a significant part of the global energy supply by 2030. In this context, First Hydrogen is playing a decisive role in the development of zero-emission transportation solutions. First Hydrogen is developing emission-free vehicles and green hydrogen production in Vancouver, Montreal and London. In partnership with AVL Powertrain and Ballard Power Systems Inc., the Company is working on hydrogen-powered light commercial vehicles with a range of over 630 km. Around 8,000 Mercedes-Benz employees in Germany are currently experiencing the fact that the green transformation can be painful. We provide the details.
Read
Commented by Armin Schulz on March 13th, 2024 | 07:30 CET
HelloFresh, Royal Helium, Evotec - Rebounds in sight
Despite all the various challenges in today's world, such as geopolitical tensions or inflation, the stock market indices have managed to climb upwards. Investors are faced with a crucial question: Where is the hidden value in a market that has already broken many records? The answer could lie in those stocks that have so far stood on the sidelines of the great rally - the silent but potentially strong performers waiting for their rebound. This strategy shifts the focus away from the usual suspects who have already posted substantial gains to stocks that are ready to initiate their own rebound, potentially unlocking significant value for patient investors in the process. We have identified three such candidates.
Read
Commented by Fabian Lorenz on March 13th, 2024 | 06:30 CET
Bayer disappoints, BioNTech share gives hope, and Cardiol Therapeutics with upside potential!
Analysts were anticipating a more favourable outcome from Bayer's Capital Markets Day. While the spin-off of Aspirin and Co. was expected, and there was also more transparency in the legal disputes, the actual results differed significantly. In some cases, analysts' share price targets plummeted by nearly 50%. In contrast, analysts have renewed their "Buy" recommendation for Cardiol Therapeutics shares. The specialist in cardiovascular diseases is facing exciting weeks and the share could certainly still more than double. There is also movement at BioNTech. In addition to operating figures, there will soon be an update on the drug pipeline. The question remains whether the share can halt its downward trend.
Read
Commented by André Will-Laudien on March 12th, 2024 | 07:15 CET
Profit-taking in Defense and AI - What else is going on? Rheinmetall, Almonty Industries, Renk and Hensoldt
Armaments stocks have been on the sunny side in the current year, 2024. Investors in this segment clearly outperformed the DAX 40 index. Due to the geopolitical situation and a redefined EU security policy, investors have rediscovered the sector. NATO member states are being called upon by the US to strictly adhere to or further increase their percentage of gross domestic product invested in defense. Donald Trump, who may return, wants to deny renegade allies the backing of the US in an emergency. Although nobody believes in this scenario, the announcement has had the effect that orders for new armaments technology have reached a new all-time high. Which shares are still in focus?
Read
Commented by Armin Schulz on March 12th, 2024 | 07:00 CET
BYD, Carbon Done Right Developments, Plug Power - Ecological responsibility becomes a success factor
Companies are faced with the urgent task of improving their carbon footprint and paving the way to climate neutrality. In an age in which environmental protection and sustainability are increasingly coming into focus, companies are called upon to act proactively and make their contribution to climate protection. Effective strategies to achieve this goal include a range of measures, from increasing energy efficiency and switching to renewable energy to optimizing transport routes and promoting a circular economy. If these steps are insufficient because the Company is too energy-hungry, the unavoidable emissions must be offset by investing in climate protection projects. Every climate-neutral company has a competitive advantage, making the achievement of this goal quite lucrative.
Read
Commented by Stefan Feulner on March 12th, 2024 | 06:45 CET
Barrick Gold, Desert Gold Ventures, Newmont - When will the next surge follow?
Gold is shining again. After reaching a new all-time high, the crisis and inflation hedge is back in the mainstream. While there has been little to read about the yellow precious metal in the newspapers in recent weeks, gold articles are currently among the most visited. During the initial impulse of the recent rise, mining stocks lagged significantly. However, if the positive trend continues, they could make up for this with disproportionately high price gains.
Read
Commented by André Will-Laudien on March 11th, 2024 | 07:00 CET
Bitcoin USD 70,000 - High-tech and artificial intelligence - a perennial favorite! Nvidia, Defense Metals, AMD and Super Micro Computer
It happened over the weekend: USD 70,000 - and no end in sight for Bitcoin? A never-ending rally seems to be taking its course after the cryptocurrency turned upwards at USD 25,000 last September. Will the upswing continue unabated? Due to the upcoming halving in April, this could continue for a few more weeks, with the crypto following growing daily. Suppliers in the high-tech sector are riding the same wave: fast computers, graphics cards, big data and artificial intelligence. Almost infinite growth is expected behind these megatrends. However, valuations are already very advanced. Where are the opportunities for newcomers now?
Read
Commented by Armin Schulz on March 11th, 2024 | 06:45 CET
Encavis, Manuka Resources, Rheinmetall - Vanadium: From metal to energy source
The energy transition presents us with the challenge of efficiently storing renewable energy. A key raw material in this process is vanadium, which is used in vanadium redox flow batteries (VRFBs) and is mainly known for its role in steel production. These batteries are characterized by their longevity, with up to 20,000 charging cycles without any significant loss of performance, and their safety as they are non-flammable. In addition, their scalability allows them to be used both in large-scale grid storage and in the private sector. By storing electricity from wind and solar power, VRFBs are a critical element in supporting the transition to a more sustainable energy supply and ensuring the availability of steel alloys that can also be used in the defense industry.
Read
Commented by Stefan Feulner on March 11th, 2024 | 06:30 CET
Novo Nordisk, Defence Therapeutics, Bayer - Rally after the breakout?
Biotechnology has been revived after a disappointing stock market year in 2023. In addition to the interest rate cut fantasy, which should benefit the capital-intensive and innovative sector in particular, the current wave of acquisitions should lead to further price rises. Although the broad Nasdaq Biotech Index has only risen by 3% since the beginning of the year, it is currently facing key resistance levels. If these are broken through, the momentum northwards could accelerate.
Read